News
The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...
In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...
Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...
Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...
Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...
Confirmation of that has come in the form of an update (PDF) from the New Jersey Department of Labour and Workforce ...
The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...
Researchers from MIT have used generative AI (genAI) algorithms to design novel antibiotics that can treat two 'superbugs' – ...
The smartphone-based CT-155 app, co-developed by Click Therapeutics and Boehringer Ingelheim, was able to help users achieve ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brendan Frey, founder and chief innovation officer of ...
Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...
The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results